The Complement System in Kidney Transplantation

卷:12

Review

关键词: ISCHEMIA-REPERFUSION INJURY;    ANTIBODY-MEDIATED REJECTION;    MESENCHYMAL STROMAL CELLS;    C1 ESTERASE INHIBITOR;    DONOR BRAIN-DEATH;    FOLLICULAR DENDRITIC CELLS;    ISCHEMIA/REPERFUSION INJURY;    STEM-CELLS;    RENAL-TRANSPLANTATION;    C5A RECEPTOR;   

DOI  :  10.3390/cells12050791

来源: SCIE

【 摘 要 】

Kidney transplantation is the therapy of choice for patients who suffer from end-stage renal diseases. Despite improvements in surgical techniques and immunosuppressive treatments, long-term graft survival remains a challenge. A large body of evidence documented that the complement cascade, a part of the innate immune system, plays a crucial role in the deleterious inflammatory reactions that occur during the transplantation process, such as brain or cardiac death of the donor and ischaemia/reperfusion injury. In addition, the complement system also modulates the responses of T cells and B cells to alloantigens, thus playing a crucial role in cellular as well as humoral responses to the allograft, which lead to damage to the transplanted kidney. Since several drugs that are capable of inhibiting complement activation at various stages of the complement cascade are emerging and being developed, we will discuss how these novel therapies could have potential applications in ameliorating outcomes in kidney transplantations by preventing the deleterious effects of ischaemia/reperfusion injury, modulating the adaptive immune response, and treating antibody-mediated rejection.